Ear Care in Brazil

July 2013 | 24 pages | ID: E385D00BAC1EN
Euromonitor International Ltd

Abstracts

ANVISA (Brazilian Health Surveillance Agency) only permits a limited number of types of ear care products to be commercialised as OTC. Therefore, sales are limited to products designed to ease minor discomfort, which result from a build-up of ear wax or fluid accumulation.

Euromonitor International's Ear Care in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Ear Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

EAR CARE IN BRAZIL
Euromonitor International
July 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Ear Care: Value 2007-2012
  Table 2 Sales of Ear Care: % Value Growth 2007-2012
  Table 3 Ear Care Company Shares by Value 2008-2012
  Table 4 Ear Care Brand Shares by Value 2009-2012
  Table 5 Forecast Sales of Ear Care: Value 2012-2017
  Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Executive Summary
Consumer Health Maintains Strong Growth
Anvisa Moves OTC Products Back To Over-the-counter
Hypermarcas Aims for Leadership
Internet Retailing: Potential Channel in Consumer Health
Consumer Health Is Expected To Maintain Its Growth Over the Forecast Period
Consumer Health Products Back To Over-the-counter
Hypermarcas Invests in Becoming the Leading Manufacturer
Middle-classes Continue To Positively Impact Consumer Health
Consumers' Health Awareness Shows Potential in Vitamins and Dietary Supplements
Illegal Sales Hamper Growth in Sports Nutrition
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
De-reimbursement
Generics
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 1 Research Sources